PATHOMATION
Board
4 directors, last change in 2024HISTODIG
Director (not named in the articles), permanent representative Wim Waelput
appointed by deed of 08-01-2024
term without a fixed end
earlier director, until 08-01-2024
listed in the 2025 annual accounts, filed on 16-07-2026
KOCKX-CONSULTING
Director (not named in the articles), permanent representative Mark Kockx
appointed by deed of 08-01-2024
term without a fixed end
earlier director, until 08-01-2024
Heitbrink Teixidor SL
Director
since 24-04-2026
listed in the 2025 annual accounts, filed on 16-07-2026
- Signing authorityThe articles say who may bind the company, for example by signing a contract.
- Each director alonedeed of 08-01-2024
Permanent representatives 2
Mandates through the years
4 names, the dashed line is todayHISTODIG
Director (not named in the articles)
Director (not named in the articles)
KOCKX-CONSULTING
Director (not named in the articles)
Director (not named in the articles)
CellCarta NV
Director
Director
Heitbrink Teixidor SL
Director
Director
BoardEarliermandate already running before its first mention
Mandates as a list
- HISTODIG
- Director (not named in the articles), since before 31-12-2021
- Director, until 08-01-2024
- KOCKX-CONSULTING
- Director (not named in the articles), since before 31-12-2021
- Director, until 08-01-2024
- CellCarta NV
- Director, since before 31-12-2025
- Heitbrink Teixidor SL
- Director, since before 31-12-2025
Control
Shareholder
Equity €25.9m
Profit €7.7m in 2025 (profit €8.8m in 2024)
Checked score 96
Source: accounts CellCarta 2025
18.52%
This company
PATHOMATION
Equity €890,585
Loss €402,294 in 2025
Capital
- Contribution
- €889,920
- Source
- 2025 annual accounts
Owners through the years
as the annual accounts name themOwners as a list
- CellCarta
Source: lists of holdings in the owners' accounts
Articles of association
- Board ruleThese rules set how the board is made up, meets and takes decisions.
- 3 directors“Maximum zes(6)jaar,onbeperkt hernieuwbaar, gedelegeerd bestuurder”deed of 29-01-2025 (in Dutch)
- Transfer restrictionThis rule says whether shareholders may sell their shares freely or need approval first.
- “Investerings-en Aandeelhoudersovereenkomst”deed of 29-01-2025 (in Dutch)
- Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
- First Saturday of June at 10:00deed of 08-01-2024 (in Dutch)